ARVN · Company research

Arvinas, Inc (ARVN): Valuation Analysis

Available valuation snapshots and ratios; unavailable metrics remain blank.

RESEARCH CONTEXT

Understand the numbers

Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.

1records availableHealthcare

Valuation Analysis data

Database-backed records only

1 rows
valuation datepricemarket capenterprise valuepeforward pepegprice salesprice bookprice fcf
Oct 8, 20267.31$485,760,000391460000.00———31.13846153846153850.86403415154749199573—

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.